article information

International Journal of Cardiovascular Practice: Vol.4, issue 4; 105-110
published online: October 30, 2019
article type: Research Article
received: August 18, 2019
accepted: October 25, 2019
DOI: https://doi.org/10.29252/ijcp-27631
Crossmark

Cardiogenic Shock Following Acute Myocardial Infarction: A Retrospective Observational Study

authors:

avatar Roxana Sadeghi 1 , 2 , avatar Zohreh Maghsoomi 3 , avatar Naser Kachoueian 2 , avatar Mohammad Sistanizad 1 , 4 , avatar Zahra Soroureddin 1 , * , avatar Mohammad Ali Akbarzadeh ORCID 5

Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Cardiovascular Research Center, Shahid Beheshti university of Medical Sciences, Tehran, Iran

how to cite: Sadeghi R, Maghsoomi Z, Kachoueian N, Sistanizad M, Soroureddin Z, et al. Cardiogenic Shock Following Acute Myocardial Infarction: A Retrospective Observational Study. Int J Cardiovasc Pract. 2019;4(4):e130564. https://doi.org/10.29252/ijcp-27631.

Abstract

Introduction: Cardiogenic shock is a sudden complication that occurs in 5 to 10% of patients with acute myocardial infarction. According to statistics, mortality and morbidity from this event, despite all hospital care, are approximately 70-80%.
Methods: This study was conducted over three years (2012 to 2014) in 28 cases of acute myocardial infarction, which was complicated by cardiovascular shock, before or after admission. We compared the outcomes of patients according to the treatment strategy, thrombolytic therapy, primary percutaneous coronary intervention (PCI), or other medical stabilization. The 30-day follow-up was the first endpoint, and the 3-month follow up was the second endpoint of the study.
Results: 28 patients with cardiogenic shock included in this study. The mean (± SD) age of the patients was 62.99 ± 13.99 years. The median time to the onset of shock was 648.75 ± 1393.58 minutes after infarction. Most of the patients who underwent coronary angiography had 3-vessel or left main involvement. Two patients missed in follow up and five (80%) patients who received thrombolytic therapy passed away. Nine (100%) patients in the medical stabilization group and six patients (50%) underwent primary PCI group passed away too. The mortality in the primary PCI group was significantly lower than the other groups (P = 0.04)
Conclusion: Although cardiogenic shock is a potential risk of early death, it is important that the thrombolytic in these patients doesn't increase survival and the primary PCI is more effective than thrombolytic agents.

Fulltext

Full-text is available in PDF file.